Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation

Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection

(2011) B Muñoz-Cobo et al.   BONE MARROW TRANSPLANTATION

High Titers of Pre-existing Adenovirus Serotype-Specific Neutralizing Antibodies in the Host Predict Viral Reactivation After Allogeneic Stem Cell Transplantation in Children

(2011) Louise A. Veltrop-Duits et al.   CLINICAL INFECTIOUS DISEASES

How I treat adenovirus in hematopoietic stem cell transplant recipients

(2010) C. A. Lindemans et al.   BLOOD

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome

(2010) L Öhrmalm et al.   BONE MARROW TRANSPLANTATION

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

(2009) A. M. Leen et al.   BLOOD

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

(2009) M Tomblyn et al.   BONE MARROW TRANSPLANTATION

Adenovirus DNA Positivity in Nasopharyngeal Aspirate Preceding Hematopoietic Stem Cell Transplantation: A Very Strong Risk Factor for Adenovirus DNAemia in Pediatric Patients

(2009) Anne P. J. de Pagter et al.   CLINICAL INFECTIOUS DISEASES

Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients

(2008) I. Gustafson et al.   JOURNAL OF CLINICAL VIROLOGY

Unmanipulated HLA 2-3 antigen–mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis

(2007) Hiroyasu Ogawa et al.   EXPERIMENTAL HEMATOLOGY